| A cross-sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update
|
| Author(s): Mariana F Almas 1, Massoud Toussi 2, Elisa Valero 3, Annick Moureau 4, Lydie Marcelon |
| Affiliations(s): 1IQVIA Real World Solutions, Porto Salvo, Portugal.
2IQVIA Real World &Analytics Solutions, La Défense, France.
3Global Pharmacovigilance, Sanofi Pasteur, Lyon, France.
4Global Biostatistical Sciences, Sanofi Pasteur, Marcy l'Etoile, France.
5Epidemiology and Benefit Risk, Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. |
Publication(s): Pharmacoepidemiol Drug Saf
. 2022 Jul;31(7):758-768. doi: 10.1002/pds.5447. Epub 2022 May 13
|
| Document Type(s): Article, |
| Countries: Brazil, Thailand, |
| Click here for the abstract |
C:
Y: |
Immunology and Vaccination, Risk Management & REMS,
2022 |
|
L:
A: |
English
Clinical setting: Primary care, Epidemiological study, Survey research, |
|
 |
| |
| |
| Insights from a review of publicly available information on Post Authorisation Safety Studies (PASS)
|
| Author(s): Almas MF, Hoogendoorn WE, Sayeed S, Blackburn S, Bosco J, Parmenter L
|
| Affiliations(s): IQVIA
|
| Publication(s): |
| Document Type(s): Poster, |
| Countries: |
C:
Y: |
Drug safety, Risk Management & REMS,
2022 |
|
L:
A: |
English
Review, |
|
|
| |
| |
| A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe. |
| Author(s): Jouaville LS, Paul T, Almas MF |
| Affiliations(s): IQVIA |
Publication(s): Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1143-1152. doi: 10.1002/pds.5301.
|
| Document Type(s): Article, |
| Countries: Europe, |
| Click here for the abstract |
C:
Y: |
Guidelines, Methodology, Risk Management & REMS,
2021 |
|
L:
A: |
English
Literature Review, |
|
|
| |
| |
| A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe
|
| Author(s): Laurence Sophie Jouaville 1, Tulika Paul 2, Mariana Ferreira Almas |
| Affiliations(s): QVIA Real World Solutions, La Defense, France.
2IQVIA Real World Solutions, Gurugram, Haryana, India.
3IQVIA Real World Solutions, Porto Salvo, Portugal. |
Publication(s): Pharmacoepidemiol Drug Saf
. 2021 Sep;30(9):1143-1152. doi: 10.1002/pds.5301. Epub 2021 Jun 24.
|
| Document Type(s): Article, |
| Countries: |
| Click here for the abstract |
C:
Y: |
Methodology, Risk Management & REMS,
2021 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
| Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use |
| Author(s): Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M |
| Affiliations(s): IQVIA |
Publication(s): Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
|
| Document Type(s): Article, |
| Countries: France, Greece, Italy, Portugal, |
| Click here for the abstract |
C:
Y: |
Musculoskeletal disease, Rheumatology, Risk Management & REMS,
2019 |
|
L:
A: |
English
Survey research, |
|
|
| |
| |
| . Lessons learned on the design and the conduct of Post-Auhorization Safety Studies: Review of 3 years of Pharmacovigilance Risk Assessment Committee (PRAC) oversight. |
| Author(s): Engel P, Almas MF, De Bruin ML, Starzyk K, Blackburn, Dreyer NA. |
| Affiliations(s): |
Publication(s): British Journal of Clinical Pharmacology
|
| Document Type(s): Article, |
| Countries: |
C:
Y: |
Risk Management & REMS,
2017 |
|
L:
A: |
English
|
|
|
| |
| |
| Evaluation of the effectiveness of risk minimisation measures: a survey among health care professionals to assess their knowledge and attitudes on prescribing conditions of Instanyl® in France and the Netherlands. |
| Author(s): Toussi M1, Garofano A1, Jouaville L1, Bardoulat I1, Mitrofan L1 |
| Affiliations(s): 1 QuintilesIMS, La Défense, France |
Publication(s): 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2017, August 26-30, Montreal, Canada
|
| Document Type(s): Poster, |
| Countries: France, Netherlands, |
C:
Y: |
Drug safety, Pain, Risk Management & REMS,
2017 |
|
L:
A: |
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Public Health, Survey research, |
|
|
| |
| |
| Between Risk Management and Pharmacoepidemiology: Where Do Post-Authorisation Safety Studies Stand Today?
|
| Author(s): Mariana F. Almas1, Pierre Engel2, Marieke L. De Bruin3, Kathryn Starzyk4, Blackburn Stella1 and Dreyer A. Nancy5 |
| Affiliations(s): 1Real-World & Late Phase Research, Reading, Berkshirek, United Kingdom; 2Real-World & Late Phase Research, France; 3Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands; 4Real-World & Late Phase Research, Cambridge, United States; 5University of North Carolina, Chapel Hill, United States |
| Publication(s): |
| Document Type(s): Abstract, |
| Countries: |
| Click here for the abstract |
C:
Y: |
Drug safety, Regulatory, Risk Management & REMS,
2016 |
|
L:
A: |
English
Review, |
|
|
| |
| |
| Risk Management in Pharmacoepidemiology |
| Author(s): Blackburn SCF. |
| Affiliations(s): |
Publication(s): Risk Management in Pharmacoepidemiology, 5th edition. Edited Strom, Kimmel & Hennessy 2012 Wiley Blackwell
|
| Document Type(s): Book chapter, |
| Countries: |
C:
Y: |
Risk Management & REMS,
2012 |
|
L:
A: |
English
RWLPR (Real-World Late Phase Research-quintiles, |
|
|
| |
| |
| Risk minimisation activities of centrally authorised products in the european union: A descriptive study |
| Author(s): Zomerdijk IM, Sayed-Tabatabaei FA, Trifirò G, Blackburn SCF, Sturkenboom MCJM, Straus SMJM |
| Affiliations(s): |
Publication(s): Pharmacoepidemiology and Drug Saf. 2011; 20:S228-S9
|
| Document Type(s): Abstract, |
| Countries: |
C:
Y: |
Risk Management & REMS,
2011 |
|
L:
A: |
English
RWLPR (Real-World Late Phase Research-quintiles, |
|
|
| |
| |
 1 of 2 
|
